Roswell Park Comprehensive Cancer Center specialists will share the latest advances and developments in the treatment of blood-related cancers at the 2022 Tandem Transplantation &...
In a recent study published in the Clinical Infectious Diseases journal, researchers assessed the impact of long coronavirus disease 2019 (COVID-19) on C-C chemokine receptor-5...
Even as the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic,...
In a recent study published in the journal Nature, the researchers investigated the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) booster vaccine...
In a recent study published in the Clinical Infectious Diseases journal, the researchers summarized the perspectives and observations on severe acute respiratory syndrome coronavirus 2...
In a recent study published in the Journal of Hepatology, researchers reported that the coronavirus disease 2019 (COVID-19) vaccination could elicit a distinct T cell-dominant...
A COVID-19 vaccine developed at the University of Washington School of Medicine has proven safe and effective in late-stage clinical testing. SK bioscience, the company...
Authorities in Wuhan, China, reported a spate of atypical pneumonia cases on December 31, 2019. The disease was dubbed coronavirus disease 19 (COVID-19), caused by...
In a recent article posted to the medRxiv* preprint server, researchers assessed the factors influencing the anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) antibodies...
The coronavirus disease 2019 (COVID-19) pandemic broke out early in 2020, following the reporting of several cases of pneumonia caused by the severe acute respiratory...
Despite evidence relating effectiveness of the current crop of vaccines used against coronavirus disease 2019 (COVID-19) in clinical trials as well as post-marketing surveillance data,...
In a recent study posted to Research Square* preprint server, researchers reported that cross-reactive antibodies against coronaviruses (CoVs) might not cross-neutralize all CoVs. Several studies...
